Sequoia Financial Advisors, LLC Abbott Laboratories Transaction History

Sequoia Financial Advisors, LLC

$8.93 Billion
Q3 2024

A detailed history of Sequoia Financial Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Sequoia Financial Advisors, LLC holds 193,764 shares of ABT stock, worth $22.3 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

193,764

Previous 162,044 19.57%

Holding current value

$22.3 Million

Previous $16.8 Million 31.21%

% of portfolio

0.25%

Previous 0.21%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$100.07 - $118.13 $3.17 Million - $3.75 Million	31,720 Added 19.57%	193,764 $22.1 Million
Q2 2024 Jul 15, 2024	BUY	$100.73 - $112.44 $2.12 Million - $2.37 Million	21,069 Added 14.95%	162,044 $16.8 Million
Q1 2024 Apr 30, 2024	SELL	$109.52 - $120.96 $1.25 Million - $1.38 Million	-11,428 Reduced 7.5%	140,975 $16 Million
Q4 2023 Jan 25, 2024	BUY	$90.19 - $110.4 $11 Million - $13.5 Million	122,428 Added 408.43%	152,403 $16.8 Million
Q3 2023 Nov 08, 2023	SELL	$95.53 - $114.62 $122,087 - $146,484	-1,278 Reduced 4.09%	29,975 $2.9 Million
Q2 2023 Aug 08, 2023	BUY	$100.78 - $112.29 $398,484 - $443,994	3,954 Added 14.48%	31,253 $3.41 Million
Q1 2023 Apr 24, 2023	SELL	$96.86 - $114.01 $190,233 - $223,915	-1,964 Reduced 6.71%	27,299 $2.76 Million
Q4 2022 Feb 10, 2023	SELL	$95.06 - $111.52 $33,841 - $39,701	-356 Reduced 1.2%	29,263 $3.21 Million
Q4 2022 Jan 17, 2023	BUY	$95.06 - $111.52 $1.25 Million - $1.47 Million	13,140 Added 79.74%	29,619 $0
Q3 2022 Oct 26, 2022	SELL	$96.76 - $112.03 $822,943 - $952,815	-8,505 Reduced 34.04%	16,479 $1.6 Million
Q2 2022 Jul 22, 2022	BUY	$102.07 - $123.37 $206,385 - $249,454	2,022 Added 8.81%	24,984 $2.72 Million
Q1 2022 May 13, 2022	SELL	$114.02 - $139.04 $696,092 - $848,839	-6,105 Reduced 21.0%	22,962 $2.72 Million
Q4 2021 Feb 11, 2022	BUY	$115.53 - $141.46 $2.67 Million - $3.27 Million	23,142 Added 390.58%	29,067 $4.09 Million
Q3 2021 Oct 26, 2021	SELL	$116.66 - $129.06 $1.78 Million - $1.97 Million	-15,249 Reduced 72.02%	5,925 $700,000
Q2 2021 Jul 27, 2021	BUY	$105.79 - $124.53 $383,806 - $451,794	3,628 Added 20.68%	21,174 $2.46 Million
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $278,521 - $328,140	2,559 Added 17.07%	17,546 $2.1 Million
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $7,140 - $7,780	-68 Reduced 0.45%	14,987 $1.64 Million
Q3 2020 Oct 23, 2020	SELL	$91.64 - $111.29 $75,328 - $91,480	-822 Reduced 5.18%	15,055 $1.64 Million
Q2 2020 Aug 11, 2020	SELL	$76.57 - $98.0 $132,772 - $169,932	-1,734 Reduced 9.85%	15,877 $1.45 Million
Q1 2020 May 11, 2020	BUY	$62.82 - $91.86 $242,987 - $355,314	3,868 Added 28.15%	17,611 $1.39 Million
Q4 2019 Feb 13, 2020	BUY	$78.51 - $87.4 $233,724 - $260,189	2,977 Added 27.65%	13,743 $1.19 Million
Q3 2019 Oct 22, 2019	SELL	$81.84 - $88.74 $11,866 - $12,867	-145 Reduced 1.33%	10,766 $901,000
Q2 2019 Jul 31, 2019	BUY	$72.88 - $85.0 $21,791 - $25,415	299 Added 2.82%	10,911 $918,000
Q1 2019 May 13, 2019	BUY	$66.22 - $80.06 $227,068 - $274,525	3,429 Added 47.74%	10,612 $848,000
Q4 2018 Feb 14, 2019	SELL	$65.56 - $74.27 $9,047 - $10,249	-138 Reduced 1.88%	7,183 $520,000
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $42,262 - $50,985	-695 Reduced 8.67%	7,321 $537,000
Q2 2018 Aug 14, 2018	BUY	$57.57 - $63.54 $34,714 - $38,314	603 Added 8.13%	8,016 $489,000
Q1 2018 May 14, 2018	BUY	$56.27 - $63.62 $50,530 - $57,130	898 Added 13.78%	7,413 $444,000
Q4 2017 Feb 13, 2018	BUY	$53.68 - $57.47 $53,572 - $57,355	998 Added 18.09%	6,515 $372,000
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $2,210 - $2,467	46 Added 0.84%	5,517 $294,000
Q2 2017 Aug 09, 2017	BUY	N/A	5,471	5,471 $266,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.31B

Call Options Held

8.74M

Put Options Held

7.89M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sequoia Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sequoia Financial Advisors, LLC with notifications on news.

Account

Sequoia Financial Advisors, LLC Abbott Laboratories Transaction History